Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
European Journal of Endocrinology
|
March 25, 2006
Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression
Mario Salvi, Guia Vannucchi, Irene Campi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 16, 2014
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study
Mario Salvi, Guia Vannucchi, Nicola Currò, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 25, 2020
Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy
Guia Vannucchi, Irene Campi, Danila Covelli, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 17, 2020
Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions
Irene Campi, Nicola Currò, Guia Vannucchi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 9, 2012
Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy
Guia Vannucchi, Danila Covelli, Nicola Currò, et al.
European Journal of Endocrinology
|
January 16, 2007
Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study
Mario Salvi, Guia Vannucchi, Irene Campi, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 15, 2014
Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy
Nicola Currò, Danila Covelli, Guia Vannucchi, et al.
Scientific Reports
|
June 1, 2018
Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathy
Lei Zhang, Giulia Masetti, Giuseppe Colucci, et al.
Frontiers in Endocrinology
|
February 11, 2022
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves' Orbitopathy
Irene Campi, Guia Vannucchi, Ilaria Muller, et al.
Ophthalmology
|
February 13, 2013
A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy
Irene Campi, Guia M Vannucchi, Andrea M Minetti, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
European Journal of Endocrinology
|
March 25, 2006
Efficacy of rituximab treatment for thyroid-associated ophthalmopathy as a result of intraorbital B-cell depletion in one patient unresponsive to steroid immunosuppression
Mario Salvi, Guia Vannucchi, Irene Campi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 16, 2014
Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study
Mario Salvi, Guia Vannucchi, Nicola Currò, et al.
Thyroid : Official Journal of the American Thyroid Association
|
November 25, 2020
Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy
Guia Vannucchi, Irene Campi, Danila Covelli, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 17, 2020
Quantification of Global Ocular Motility Impairment in Graves' Orbitopathy by Measuring Eye Muscle Ductions
Irene Campi, Nicola Currò, Guia Vannucchi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
March 9, 2012
Serum BAFF concentrations in patients with Graves' disease and orbitopathy before and after immunosuppressive therapy
Guia Vannucchi, Danila Covelli, Nicola Currò, et al.
European Journal of Endocrinology
|
January 16, 2007
Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study
Mario Salvi, Guia Vannucchi, Irene Campi, et al.
Thyroid : Official Journal of the American Thyroid Association
|
January 15, 2014
Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy
Nicola Currò, Danila Covelli, Guia Vannucchi, et al.
Scientific Reports
|
June 1, 2018
Combining micro-RNA and protein sequencing to detect robust biomarkers for Graves' disease and orbitopathy
Lei Zhang, Giulia Masetti, Giuseppe Colucci, et al.
Frontiers in Endocrinology
|
February 11, 2022
Therapy With Different Dose Regimens of Rituximab in Patients With Active Moderate-To-Severe Graves' Orbitopathy
Irene Campi, Guia Vannucchi, Ilaria Muller, et al.
Ophthalmology
|
February 13, 2013
A quantitative method for assessing the degree of axial proptosis in relation to orbital tissue involvement in Graves' orbitopathy
Irene Campi, Guia M Vannucchi, Andrea M Minetti, et al.
Page
of 6